XML 139 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue (Tables)
12 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue Reserves for sales returns consist of the following (in thousands):
Years ended June 30,
20232022
Beginning balance$131 $197 
Additions1,978 1,616 
Returns(1,980)(1,682)
Ending balance$129 $131 
The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):
 Years ended June 30,
 20232022
Americas$155,361 $138,323 
Asia/Pacific & Europe58,037 68,037 
Total revenue$213,398 $206,360 
Additional information as to the Company’s revenue from operations in the most significant geographical areas is set forth below (in thousands):
 Years ended June 30,
 20232022
United States$148,522 $130,932 
Japan$32,082 $36,810 
Schedule of Revenues by Major Product Line The following table shows revenue by major product line for the fiscal years ended June 30, 2023 and 2022:
Years ended June 30,
20232022
Protandim® product line
$119,720 56.1 %$135,616 65.7 %
TrueScience® product line
49,494 23.2 %22,877 11.1 %
Other44,184 20.7 %47,867 23.2 %
Total$213,398 100.0 %$206,360 100.0 %